TRAVERE THERAPEUTICS
LIVE

Serial Number

88758429

Owner

TRAVERE THERAPEUTICS, INC.

Attorney

Jared M. Barrett

First Use Date

Feb 17, 2023

Filing Date

Jan 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TRAVERE THERAPEUTICS Trademark

Serial Number: 88758429 • Registration: 7115678

TRAVERE THERAPEUTICS is a trademark filed by TRAVERE THERAPEUTICS, INC. on January 14, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

TRAVERE THERAPEUTICS, INC. (67 trademarks)

SUITE 300
SAN DIEGO, CA 92130

Entity Type: 03

RETROPHIN, INC. (70 trademarks)

Suite 200
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

January 14, 2020

Registration Date

July 18, 2023

First Use Anywhere

February 17, 2023

First Use in Commerce

February 17, 2023

Published for Opposition

May 12, 2020

Goods & Services

Providing health and medical information; providing a website featuring health and medical information

Research and development of pharmaceuticals for the treatment of rare diseases; medical research

pharmaceutical preparations for the treatment of kidney diseases and disorders; therapeutic preparations for the treatment of kidney diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 18, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 18, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 10, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 9, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 7, 2023 SUPC
USE AMENDMENT FILED
Jun 1, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 1, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2023 EXRA
SOU EXTENSION 5 GRANTED
Jan 25, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 25, 2023 AITU
SOU EXTENSION 5 FILED
Jan 9, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 9, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 30, 2022 EXRA
SOU EXTENSION 4 GRANTED
Jun 28, 2022 EX4G
SOU EXTENSION 4 FILED
Jun 28, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 28, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2021 EXRA
SOU EXTENSION 3 GRANTED
Dec 10, 2021 EX3G
SOU EXTENSION 3 FILED
Dec 10, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 10, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jun 16, 2021 EX2G
SOU EXTENSION 2 FILED
Jun 16, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 16, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 1, 2021 EXRA
SOU EXTENSION 1 GRANTED
Dec 30, 2020 EX1G
SOU EXTENSION 1 FILED
Dec 30, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 30, 2020 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 23, 2020 ASGN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 7, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2020 NONP
ASSIGNED TO LIE
Apr 2, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 23, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 23, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 23, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 23, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 10, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 10, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 10, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 18, 2020 NWOS
NEW APPLICATION ENTERED
Jan 17, 2020 NWAP